REQUEST A DEMO
Total
USD $0.00
Search more companies

Bristol Myers Squibb de Colombia S.A. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Bristol Myers Squibb de Colombia S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Importacion,exportacion,manufactura,compra y venta de preparaciones farmaceuticas,medicas, quimicas biologicas e insecticidas,drogas, medicinas,antibioticos.

Headquarters
Centro de Negocios Regus, Carrera 7 # 71 - 21, Edificio Avenida Chile, Torre B, Piso 13, Oficina 16
Bogota D.C.; Bogota D.C; Postal Code: 0208

Contact Details: Purchase the Bristol Myers Squibb de Colombia S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Bristol Myers Squibb de Colombia S.A. report to view the information.
Outstanding Shares:
Purchase the Bristol Myers Squibb de Colombia S.A. report to view the information.
Registered Capital:
Purchase the Bristol Myers Squibb de Colombia S.A. report to view the information.
Incorporation Date:
January 29, 1963
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Subsidiaries
Bristol-Myers Squibb Commpany
Company Performance
Financial values in the chart are available after Bristol Myers Squibb de Colombia S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
13.79%
Total operating revenue
14.41%
Operating profit (EBIT)
11.64%
EBITDA
10.16%
Net Profit (Loss) for the Period
-50.02%
Total assets
-20.05%
Total equity
50.28%
Operating Profit Margin (ROS)
-0.06%
Net Profit Margin
-0.79%
Return on Equity (ROE)
0.02%
Quick Ratio
0.77%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?